Evidence mapPaperPMID 40957982Full record

ReviewThe EMBO journal2025

Decoding immunometabolism with next-generation tools: lessons from dendritic cells and T cells.

Yi-Hao Wang, Limei Wang, Ping-Chih Ho

Abstract readReview
In one paragraph

Review in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yi-Hao Wang *Department of Oncology, University of Lausanne, Lausanne, Switzerland.ORCID http://orcid.org/0009-0004-3972-4206
Limei Wang *Department of Oncology, University of Lausanne, Lausanne, Switzerland. limei.wang@unil.ch.ORCID http://orcid.org/0000-0002-3462-7720
Ping-Chih HoDepartment of Oncology, University of Lausanne, Lausanne, Switzerland. ping-chih.ho@unil.ch.ORCID http://orcid.org/0000-0003-3078-3774

Funding

Swiss Caner foundation KLS-5949-08-2023Swiss National Science Foundation 310030_215126Swiss National Science Foundation 310030L_208130Swiss National Science Foundation CRSII5_205930Swiss National Science Foundation IZLCZ0_206083Swiss National Science Foundation TMCF-3_213736
6 · The paper itself

Abstract

Cellular metabolism plays a pivotal role in regulating the effector functions and fate decisions of immune cells, shaping immune responses in homeostasis and disease. Metabolic pathways also serve as critical signaling hubs governing immune cell behavior. Deregulated metabolic pathways contribute to immune dysfunction, fueling disease progression and creating challenges for therapeutic interventions. The recent development of advanced technologies to delineate immunometabolic regulation has revolutionized our understanding of immune cell biology. These tools, ranging from quantitative single-cell metabolomics to in vivo spatial tissue profiling and DC-based metabolic therapy, have shifted the focus from broad nutrient pathways to a detailed exploration of metabolic reprogramming within disease microenvironments, revealing how metabolic changes drive immune cell activation, differentiation, and effector responses. The integration of immunometabolic insights into clinical practice holds strong potential for advancing precision medicine and developing targeted therapies that restore immune balance in pathological conditions. Here, we summarize emerging cutting-edge technologies related to immunometabolism and critically reflect on their current limitations. Finally, we discuss potential needs for developing novel methods that can uncover the intricate interplay between metabolism and immune cell function.

Indexed as

Dendritic CellsMetabolomicsT-LymphocytesAnimalsHumansMetabolic Networks and PathwaysDendritic CellsImmunometabolismMetabolic ReprogrammingT CellsTechnological Advances

Identifiers

PMID40957982
PMCPMC12583481

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.